Safety of montelukast in children with post-RSV-bronchiolitic respiratory symptoms

T. Reiss, B. Knorr, R. Massaad, S. Lu, K. Newcomb, H. Bisgaard (Rahway, NJ, United States Of America; Copenhagen, Denmark)

Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Session: Anti-inflammatory therapy for childhood asthma
Session type: Electronic Poster Discussion
Number: 2717
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Reiss, B. Knorr, R. Massaad, S. Lu, K. Newcomb, H. Bisgaard (Rahway, NJ, United States Of America; Copenhagen, Denmark). Safety of montelukast in children with post-RSV-bronchiolitic respiratory symptoms. Eur Respir J 2007; 30: Suppl. 51, 2717

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical disposition, safety and efficacy of fluticasone propionate (FP) in pre-school children with persistent wheeze and asthma-like symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 219s
Year: 2002

Safety of tiotropium in pre-school children with symptomatic persistent asthma
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Safety of once-daily QMF149 in patients with persistent asthma
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012


Effect of fluticasone and montelukast in preschool children with asthma-like symptoms
Source: Eur Respir J 2006; 28: Suppl. 50, 709s
Year: 2006

Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Safety and efficacy of omalizumab in children with allergic asthma
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Safety of omalizumab therapy in children with allergic asthma
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Oral montelukast in patients with acute severe asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007


Safety of inhaled corticosteroids reduction in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

LATE-BREAKING ABSTRACT: Safety and tolerability of once-daily tiotropium Respimat® add-on therapy in children with moderate symptomatic asthma
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016


Efficacy of montelukast in Indian patients having chronic persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003

Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Comparative evaluation of desloratadine versus levocetirizine in managing patients with comorbid rhinitis and asthma in the United Kingdom
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Safety and efficacy of momethason furoate for usage in school children with mild to moderate persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 290s
Year: 2003

Comparison of formoterol and terbutaline for treatment of asthma exacerbations in children and adolescents
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Efficacy of cetirizine and pseudoephedrine in school children with seasonal allergic rhinitis and mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002

Perceived bronchodilator efficacy during severe asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



Asthma exacerbations in children receiving montelukast vs. other controllers in Italy
Source: Eur Respir J 2005; 26: Suppl. 49, 618s
Year: 2005